Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/2950359

Download in:

View as

General Info

PMID
2950359